West Pharmaceutical
692 hedge funds and large institutions have $24B invested in West Pharmaceutical in 2023 Q1 according to their latest regulatory filings, with 126 funds opening new positions, 246 increasing their positions, 217 reducing their positions, and 55 closing their positions.
Holders
692
Holders Change
+58
Holders Change %
+9.15%
% of All Funds
11.08%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.18%
New
126
Increased
246
Reduced
217
Closed
55
Calls
$60.1M
Puts
$24.1M
Net Calls
+$36M
Net Calls Change
+$37.4M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$381M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$398M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$985M |
| 4 |
4
JPMorgan Chase & Co
New York
|
$294M |
| 5 |
5
Alyeska Investment Group
Chicago,
Illinois
|
$78.8M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
751
Walleye Trading
New York
| – | – | – | – |
|
|
EAM
752
Erste Asset Management
Vienna,
Austria
| – | – | – | – |
|
753
Capstone Investment Advisors
New York
| – | – | – | – |
|
|
SWG
754
Summit Wealth Group
White River Junction,
Vermont
| $0 | 13,512 | +13,512 | New |
|